FOx Biosystems

FOx Biosystems aims to revolutionize the life sciences industry and research market using its real-time, label-free analysis technology.

The FOx technology is based on an innovative fiber-optic-based surface plasmon resonance biosensor technology. This enables the users to generate high quality biomolecular data such as affinity data, kinetic data and concentration measurements. FOx biosensor technology has several benefits compared to existing biomolecular analysis tools, including ease of use, speed, wide applicability and cost-effectiveness.

FOx Biosystems sells instruments, reagents and services to improve biomolecular interaction analysis in life science research and industry. Fox Biosystems was founded in 2017 as a spin-off of the KU Leuven. In 2019 Fox Biosystems secured 4 million euros in capital with the Limburgse Investeringsmaatschappij LRM, the Gemma Frisius Fund and several biotech investors.